Literature DB >> 8872769

Frequency and factors influencing portal hypertensive gastropathy and duodenopathy in cirrhotic portal hypertension.

R Gupta1, V A Saraswat, M Kumar, S R Naik, R Pandey.   

Abstract

Portal hypertensive gastropathy and duodenopathy are distinct clinical and endoscopic entities. Data on factors influencing the development of these lesions are still emerging. Data on portal hypertensive duodenopathy are scarce. We prospectively studied 230 patients with liver cirrhosis and oesophageal varices attending the liver clinic of the Sanjay Gandhi Post Graduate Institute of Medical Sciences. One hundred and forty-two patients had no history of upper gastrointestinal bleeding, while the remainder had bled in the past. Endoscopic appearances were recorded before starting patients on a sclerotherapy programme. Forty-four patients were re-evaluated after variceal eradication. The frequency of portal hypertensive gastropathy (PHG) and duodenopathy (PHD) was 61 and 14%, respectively. Mild PHG was present in 85% and was severe in the rest. Portal hypertensive duodenopathy was mild in 50%, while in the other half it was severe. There was no relationship of PHG and PHD to: (i) a history of upper gastrointestinal bleed; (ii) size of oesophageal varices; (iii) aetiology of liver cirrhosis; or (iv) liver function status as assessed by Child Pugh's scores (P = NS for all). The prevalence of PHG was higher in those patients with oesophagogastric varices (74 of 107; 69%) compared with patients with oesophageal varices alone (68 of 123; 55%; P < 0.05). However, no such increase in frequency of PHD was noted in patients with oesophagogastric varices. Sclerotherapy increased the frequency of PHG. Twenty-four patients had PHG before starting sclerotherapy, while it was noted in 33 patients 1-3 months after variceal eradication (P < 0.05). In contrast, there was no increase in the prevalence of portal hypertensive duodenopathy after sclerotherapy (P = NS). There was no correlation between endoscopic and histological changes of PHG and PHD. In conclusion, PHG is quite frequent in patients with cirrhosis and its frequency increases with the presence of oesophagogastric varices and after sclerotherapy. However, the frequency of PHD is low and is not affected by the factors studied.

Entities:  

Mesh:

Year:  1996        PMID: 8872769     DOI: 10.1111/j.1440-1746.1996.tb00322.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

3.  Portal hypertensive duodenal polyp: a case report.

Authors:  Jean-David Zeitoun; Ariane Chryssostalis; Benoit Terris; Frederic Prat; Marianne Gaudric; Stanislas Chaussade
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

4.  Effect of portal hypertension in the small bowel: an endoscopic approach.

Authors:  Pedro Figueiredo; Nuno Almeida; Clotilde Lérias; Sandra Lopes; Hermano Gouveia; Maximino C Leitão; Diniz Freitas
Journal:  Dig Dis Sci       Date:  2007-11-17       Impact factor: 3.199

5.  Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study.

Authors:  Reda Elwakil; Ashraf Mohammad Al Breedy; Hoda Hassan Abou Gabal
Journal:  Hepatol Int       Date:  2016-03-01       Impact factor: 6.047

6.  Duodenal polyposis secondary to portal hypertensive duodenopathy.

Authors:  Ananta Gurung; Philip E Jaffe; Xuchen Zhang
Journal:  World J Gastrointest Endosc       Date:  2015-11-25

7.  Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

Review 8.  Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice.

Authors:  Rafael F Perini; Paula R S Camara; Jose G P Ferraz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03

9.  Gastrointestinal Bleeding Secondary to Portal Hypertensive Duodenopathy in a Patient with Decompensated Liver Cirrhosis.

Authors:  Rohini Krishna; Samuel O Igbinedion; Richie Diaz; Nazneen Hussain; Moheb Boktor
Journal:  Case Rep Gastrointest Med       Date:  2018-10-18

10.  Portal hypertensive duodenopathy manifesting as "kissing" duodenal ulcers in a nigerian with alcoholic cirrhosis: a case report and brief review of the literature.

Authors:  Aderemi Oluyemi; Adeniyi Amole
Journal:  Case Rep Med       Date:  2012-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.